Depression Drugs Market Reports 2018-2025: Lundbeck, Allergan, GSK, Pfizer, Eli Lilly, Astrazeneca, Lundbeck, Allergan
The global depression drugs market is segmented based on various depression medication classes, brand and geography. Based on the depression medication classes, the market is sub-segmented into monoamine oxidase inhibitors (MAOIs), serotonin-norepinephrine reuptake inhibitors (SNRI), anticonvulsants, beta-blockers, tetracyclic antidepressants (TeCAs), benzodiazepines, selective serotonin reuptake inhibitors (SSRIs) and others. Amongst the medication classes, SNRI is the highest revenue segment in the current scenario.
View full press release